Plasmatech Biopharmaceuticals


Company Update (NASDAQ:PTBI): Plasmatech Biopharmaceuticals Inc Expands Rare Disease Pipeline With License Agreement For Gene Therapy

Plasmatech Biopharmaceuticals Inc (NASDAQ:PTBI), a biopharmaceutical company focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases, announced …

Company Update (NASDAQ:PTBI): Plasmatech Biopharmaceuticals Inc Annouces Appointment Of Todd Wider, MD To Board Of Directors

PlasmaTech Biopharmaceuticals Inc (NASDAQ:PTBI), a biopharmaceutical company focused on advancing cell therapy and gene therapy for rare diseases,  announced that Todd Wider, MD …

Stay Ahead of Everyone Else

Get The Latest Stock News Alerts